Michael Corvelli

Associate, Public Equity

Michael joined Sofinnova as an Associate in 2018. He focuses on public investments in global biopharmaceutical companies. Michael will be working with Eric in managing Sofinnova’s public equities portfolio.

Before joining Sofinnova, Michael covered biotech and pharma at Citadel LLC, a global multi-strategy hedge fund. Prior to his experience on the buyside, he worked as a sellside biotech analyst/associate at Jefferies & Co and held a research scientist position at Johns Hopkins School of Medicine. During his time at Johns Hopkins, Michael developed and patented a novel binding peptide for use in tissue repair and authored multiple peer reviewed journal articles, including publications in Nature Materials, Methods, and Journal of Biomedical Research.

Michael received a Master of Science in Biomedical Engineering from Johns Hopkins University, a BS in Mechanical Engineering and Applied Mathematics from Rutgers and holds a certificate in business analytics through Harvard Business School.

Assistant: Josie Kastelic

Email: josie@sofinnova.com


(650) 681-8488